Plain-English translation of NCT01419561 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a research study designed to carefully observe and document how a newly recognized illness caused by the KSHV virus develops over time. Researchers want to understand the pattern of symptoms, blood test abnormalities, and imaging findings in people with this condition so they can eventually develop better treatments. The study will follow people with this illness to learn more about what happens to them over months and years.
This is a newly recognized illness, and doctors still don't fully understand how it progresses, what causes some people to get sicker than others, or what the best treatments might be. This study will create a detailed picture of the illness so that future treatments can be developed more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will visit the National Cancer Institute regularly for doctors to examine you, ask about your symptoms, and run blood tests and imaging scans. The study is primarily observational, meaning researchers will watch and document how your illness changes over time rather than giving everyone the same treatment — though if you need specific treatment, that can be arranged. You will remain in the study for an extended period so doctors can understand the long-term course of this illness.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States